AbacavirInfectious DiseasesHLA-BBoxed Warning, Dosage and Administration, Contraindications, Warnings and PrecautionsAbemaciclib (1)OncologyESR(Hormone Receptor)Indications and Usage, Adverse Reactions, Clinical StudiesAbemaciclib (2)OncologyERBB2(HER2)Indications and Usage, Adverse Reactions, Clinical StudiesAbemaciclib (3)OncologyMKI67Indications and Usage, Dosage and Administration, Clinical StudiesAbrocitinibDermatologyCYP2C19Dosage and Administration, Use in Specific Populations, Clinical PharmacologyAdo-Trastuzumab EmtansineOncologyERBB2(HER2)Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical StudiesAducanumab-avwaNeurologyAPOEWarnings and Precautions, Clinical StudiesAfatinibOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesAlectinibOncologyALKIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical StudiesAlglucosidase AlfaInborn Errors of MetabolismGAAWarnings and PrecautionsAllopurinolOncologyHLA-BWarningsAlpelisib (1)OncologyERBB2(HER2)Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesAlpelisib (2)OncologyESR(Hormone Receptor)Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesAlpelisib (3)OncologyPIK3CAIndication and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesAmifampridineNeurologyNAT2Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical PharmacologyAmifampridine PhosphateNeurologyNAT2Dosage and Administration, Use in Specific Populations, Clinical PharmacologyAmitriptylinePsychiatryCYP2D6PrecautionsAmivantamab-vmjwOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesAmoxapinePsychiatryCYP2D6PrecautionsAmphetaminePsychiatryCYP2D6Clinical PharmacologyAnakinraRheumatologyNLRP3Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesAnastrozoleOncologyESR, PGR(Hormone Receptor)Indications and Usage, Adverse Reactions, Drug Interactions, Clinical StudiesAnifrolumab-fniaRheumatologyGene Signature(IFN)Clinical Pharmacology, Clinical StudiesArformoterol (1)PulmonaryUGT1A1Clinical PharmacologyArformoterol (2)PulmonaryCYP2D6Clinical PharmacologyAripiprazolePsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical PharmacologyAripiprazole LauroxilPsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical PharmacologyArsenic TrioxideOncologyPML-RARAIndications and Usage, Clinical StudiesArticaine and Epinephrine (1)AnesthesiologyG6PDWarnings and PrecautionsArticaine and Epinephrine (2)AnesthesiologyNonspecific(Congenital Methemoglobinemia)Warnings and PrecautionsAsciminibOncologyBCR-ABL1(Philadelphia chromosome)Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical StudiesAtezolizumab (1)OncologyCD274(PD-L1)Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical StudiesAtezolizumab (2) OncologyGene Signature(T-effector)Clinical StudiesAtezolizumab (3)OncologyEGFRIndications and Usage, Adverse Reactions, Clinical StudiesAtezolizumab (4)OncologyALKIndications and Usage, Adverse Reactions, Clinical StudiesAtezolizumab (5)OncologyBRAFIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesAtomoxetinePsychiatryCYP2D6Dosage and Administration, Warnings and Precautions, Adverse Reactions, Drug Interactions, Use in Specific Populations, Clinical PharmacologyAscorbic Acid, PEG-3350, Potassium Chloride, Sodium Ascorbate, Sodium Chloride, and Sodium SulfateGastroenterologyG6PDWarnings and Precautions, Adverse ReactionsAvapritinib (1)OncologyPDGFRAIndications and Usage, Dosage and Administration, Clinical StudiesAvapritinib (2)OncologyKITClinical StudiesAvatrombopag (1)HematologyF2(Prothrombin)Warnings and PrecautionsAvatrombopag (2)HematologyF5(Factor V Leiden)Warnings and PrecautionsAvatrombopag (3)HematologyPROCWarnings and PrecautionsAvatrombopag (4)HematologyPROS1Warnings and PrecautionsAvatrombopag (5)HematologySERPINC1(Antithrombin III)Warnings and PrecautionsAvatrombopag (6)HematologyCYP2C9Clinical PharmacologyAvelumabOncologyCD274(PD-L1)Clinical StudiesAzacitidine (1)OncologyCBLClinical StudiesAzacitidine (2)OncologyPTPN11Clinical StudiesAzacitidine (3)OncologyRASClinical StudiesAzathioprine (1)RheumatologyTPMTDosage and Administration, Warnings, Precautions, Drug Interactions, Adverse Reactions, Clinical PharmacologyAzathioprine (2)RheumatologyNUDT15Dosage and Administration, Warnings, Precautions, Adverse Reactions, Clinical PharmacologyBelinostatOncologyUGT1A1Dosage and Administration, Clinical PharmacologyBelzutifan (1)OncologyCYP2C19Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical PharmacologyBelzutifan (2)OncologyUGT2B17Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical PharmacologyBelzutifan (3)OncologyVHLClinical StudiesBinimetinib (1)OncologyBRAFIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical StudiesBinimetinib (2)OncologyUGT1A1Clinical PharmacologyBlinatumomab (1)OncologyBCR-ABL1(Philadelphia chromosome)Adverse Reactions, Clinical StudiesBlinatumomab (2)OncologyCD19Indications and UsageBoceprevirInfectious DiseasesIFNL3(IL28B)Clinical PharmacologyBosutinibOncologyBCR-ABL1(Philadelphia chromosome)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical StudiesBrentuximab Vedotin (1)OncologyALKClinical StudiesBrentuximab Vedotin (2)OncologyTNFRSF8(CD30)Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical StudiesBrexpiprazolePsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical PharmacologyBrigatinibOncologyALKIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesBrivaracetamNeurologyCYP2C19Clinical PharmacologyBupivacaine (1) AnesthesiologyG6PDWarningsBupivacaine (2)AnesthesiologyNonspecific(Congenital Methemoglobinemia)WarningsBupropionPsychiatryCYP2D6Clinical PharmacologyBusulfanOncologyBCR-ABL1(Philadelphia chromosome)Clinical StudiesCabotegravir and Rilpivirine (1)Infectious DiseasesHLA-BClinical StudiesCabotegravir and Rilpivirine (2)Infectious DiseasesUGT1A1Clinical PharmacologyCabozantinibOncologyRETClinical StudiesCapmatinibOncologyMETIndications and Usage, Dosage and Administration, Clinical StudiesCapecitabineOncologyDPYDWarnings and Precautions, Patient Counseling InformationCarbamazepine (1)NeurologyHLA-BBoxed Warning, Warnings, PrecautionsCarbamazepine (2)NeurologyHLA-AWarningsCarglumic AcidInborn Errors of MetabolismNAGSIndications and Usage, Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesCariprazinePsychiatryCYP2D6Clinical PharmacologyCarisoprodolRheumatologyCYP2C19Use in Specific Populations, Clinical PharmacologyCarvedilolCardiologyCYP2D6Drug Interactions, Clinical PharmacologyCasimersenNeurologyDMDIndications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesCeftriaxone (1)Infectious DiseasesG6PDWarningsCeftriaxone (2)Infectious DiseasesNonspecific(Congenital Methemoglobinemia)WarningsCelecoxibRheumatologyCYP2C9Dosage and Administration, Use in Specific Populations, Clinical PharmacologyCemiplimab-rwlc (1)OncologyALKIndications and Usage, Clinical StudiesCemiplimab-rwlc (2)OncologyCD274(PD-L1)Indications and Usage, Dosage and Administration, Clinical StudiesCemiplimab-rwlc (3)OncologyEGFRIndications and Usage, Clinical StudiesCemiplimab-rwlc (4)OncologyROS1Indications and Usage, Clinical StudiesCeritinibOncologyALKIndications and Usage, Dosage and Administration, Warning and Precautions, Adverse Reactions, Clinical StudiesCerliponase AlfaInborn Errors of MetabolismTPP1Indications and Usage, Use in Specific Populations, Clinical StudiesCetuximab (1)OncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesCetuximab (2)OncologyRASIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical StudiesCetuximab (3)OncologyBRAFIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical StudiesCevimelineDentalCYP2D6PrecautionsChloroprocaine (1)AnesthesiologyG6PDWarningsChloroprocaine (2)AnesthesiologyNonspecific(Congenital Methemoglobinemia)WarningsChloroquineInfectious DiseasesG6PDPrecautions, Adverse ReactionsChlorpropamideEndocrinologyG6PDPrecautionsCholic AcidInborn Errors of MetabolismAMACR, AKR1D1, CYP7A1, CYP27A1, DHCR7, HSD3B2(Bile Acid Synthesis Disorders)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical StudiesCisplatinOncologyTPMTAdverse ReactionsCitalopram (1)PsychiatryCYP2C19Dosage and Administration, Warnings,Clinical PharmacologyCitalopram (2)PsychiatryCYP2D6Clinical PharmacologyClobazamNeurologyCYP2C19Dosage and Administration, Use in Specific Populations, Clinical PharmacologyClomipraminePsychiatryCYP2D6PrecautionsClopidogrelCardiologyCYP2C19Boxed Warning, Warnings and Precautions, Clinical PharmacologyClozapinePsychiatryCYP2D6Dosage and Administration, Use in Specific Populations, Clinical PharmacologyCobimetinibOncologyBRAFIndications and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesCodeineAnesthesiologyCYP2D6Boxed Warning, Warnings and Precautions, Use in Specific Populations, Patient Counseling InformationCrizanlizumab-tmcaHematologyHBBAdverse Reactions, Clinical StudiesCrizotinib (1)OncologyALKIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesCrizotinib (2)OncologyROS1Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical StudiesDabrafenib (1)OncologyBRAFIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesDabrafenib (2)OncologyG6PDWarnings and Precautions, Adverse Reactions, Patient Counseling InformationDabrafenib (3)OncologyRASDosage and Administration, Warnings and PrecautionsDaclatasvirInfectious DiseasesIFNL3(IL28B)Clinical StudiesDacomitinibOncologyEGFRIndications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical StudiesDapsone (1)DermatologyG6PDWarnings and Precautions, Use in Specific Populations, Patient Counseling InformationDapsone (2)DermatologyNonspecific(Congenital Methemoglobinemia)Warnings and Precautions, Adverse Reactions, Patient Counseling InformationDapsone (3)Infectious DiseasesG6PDPrecautions, Adverse Reactions, OverdosageDarifenacinUrologyCYP2D6Clinical PharmacologyDasabuvir, Ombitasvir, Paritaprevir, andRitonavirInfectious DiseasesIFNL3(IL28B)Clinical StudiesDasatinibOncologyBCR-ABL1(Philadelphia chromosome)Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical StudiesDenileukin DiftitoxOncologyIL2RA(CD25 antigen)Indications and Usage, Clinical StudiesDesipraminePsychiatryCYP2D6PrecautionsDesfluraneAnesthesiologyNonspecific(Genetic Susceptibility to Malignant Hyperthermia)ContraindicationsDesvenlafaxinePsychiatryCYP2D6Clinical PharmacologyDeutetrabenazineNeurologyCYP2D6Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical PharmacologyDexlansoprazoleGastroenterologyCYP2C19Drug Interactions, Clinical PharmacologyDextromethorphan and QuinidineNeurologyCYP2D6Warnings and Precautions, Clinical PharmacologyDiazepamNeurologyCYP2C19Clinical PharmacologyDinutuximabOncologyMYCNClinical StudiesDocetaxelOncologyESR, PGR(Hormone Receptor)Clinical StudiesDolutegravirInfectious DiseasesUGT1A1Clinical PharmacologyDonepezilNeurologyCYP2D6Clinical PharmacologyDostarlimab-gxlyOncologyMismatch RepairIndication and Usage, Dosage and Administration, Adverse Reactions, Clinical StudiesDoxepin (1)PsychiatryCYP2D6Clinical PharmacologyDoxepin (2)PsychiatryCYP2C19Clinical PharmacologyDronabinolGastroenterologyCYP2C9Use in Specific Populations, Clinical PharmacologyDrospirenone and Ethinyl EstradiolGynecologyCYP2C19Clinical PharmacologyDuloxetinePsychiatryCYP2D6Drug InteractionsDurvalumabOncologyCD274(PD-L1)Clinical Pharmacology, Clinical StudiesDuvelisibOncologyChromosome 17pClinical StudiesEculizumab (1)NeurologyACHRIndications and Usage, Clinical StudiesEculizumab (2)NeurologyAQP4Indications and Usage, Clinical StudiesEfavirenzInfectious DiseasesCYP2B6Clinical PharmacologyEfgartigimod Alfa-fcabNeurologyACHRIndications and Usage, Clinical Pharmacology, Clinical StudiesElagolixGynecologySLCO1B1Clinical PharmacologyElbasvir and GrazoprevirInfectious DiseasesIFNL3(IL28B)Clinical StudiesElexacaftor, Ivacaftor, and TezacaftorPulmonaryCFTRIndications and Usage, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesEliglustatInborn Errors of MetabolismCYP2D6Indications and Usage, Dosage and Administration, Contraindications, Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesElosulfaseInborn Errors of MetabolismGALNSIndications and Usage, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesEltrombopag (1)HematologyF5(Factor V Leiden)Warnings and PrecautionsEltrombopag (2)HematologySERPINC1(Antithrombin III)Warnings and PrecautionsEltrombopag (3)HematologyChromosome 7Adverse ReactionsEltrombopag (4)HematologyChromosome 13Adverse ReactionsEmapalumab-lzsgHematologyPRF1, RAB27A, SH2D1A, STXBP2, STX11, UNC13D, XIAP (Hemophagocytic Lymphohistiocytosis)Clinical StudiesEnasidenibOncologyIDH2Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical StudiesEncorafenib (1)OncologyBRAFIndications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical StudiesEncorafenib (2)OncologyRASDosage and Administration, Warnings and Precautions, Clinical StudiesEnfortumab Vedotin-ejfvOncology
NECTIN4
SERPINC1(Antithrombin III)
ERBB2(HER2)
Indications and Usage, Adverse Reactions, Clinical Studies
Clinical Studies
Indications and Usage, Clinical Studies
See the article here:
Table of Pharmacogenomic Biomarkers in Drug Labeling | FDA
Recommendation and review posted by G. Smith
